Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

The most recent COVID-19 vaccines from Moderna and Pfizer were approved by the FDA on Aug. 24, with the CDC recommending Americans get their updated shots ahead of the winter virus season. Amish ...

Jackson County Health Department (JCHD) is now providing flu vaccinations by appointment. An annual flu vaccination is ...

Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...

Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...

Warning: COVID Vaccines Linked to Cancer Risks, Experts Say** In a shocking revelation that could alter the narrative surrounding COVID-19 vaccinations, a prominent molecular vi ...

We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.” ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...